RPS6KB1 and ovarian cancer: Overall, it was confirmed that fucosterol inhibits p-ERK1/2 and p-P38 upstream of the signaling mechanism in ovarian cancer, thereby inhibiting the downstream PI3K/MAPK and p-P70S6K signaling mechanisms.